Detalhe da pesquisa
1.
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation
; 147(14): 1067-1078, 2023 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36876483
2.
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
N Engl J Med
; 385(20): 1845-1855, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758252
3.
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER.
J Card Fail
; 30(3): 436-448, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104937
4.
Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy.
Circulation
; 146(14): 1067-1081, 2022 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082663
5.
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial.
Circulation
; 146(23): 1749-1757, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36321459
6.
Excess mortality in solid organ transplant recipients hospitalized with COVID-19: A large-scale comparison of SOT recipients hospitalized with or without COVID-19.
Clin Transplant
; 36(1): e14492, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558116
7.
Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team.
J Thromb Thrombolysis
; 54(3): 449-460, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36057054
8.
Pulmonary Congestion and Left Ventricular Dysfunction After Myocardial Infarction: Insights From the PARADISE-MI Trial.
Circulation
; 149(4): 335-338, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252738
9.
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. Reply.
N Engl J Med
; 386(6): 603, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139283
10.
Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial.
Circulation
; 145(1): 87-89, 2022 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797725
11.
Prognostic Value of Natriuretic Peptides and Cardiac Troponins in COVID-19.
Circulation
; 144(2): 177-179, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33999648
12.
From practice changing to hypothesis generating: a virtuous cycle.
Eur Heart J
; 41(8): 955-957, 2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31819980
13.
Parenteral nutrition as an unexpected and preventable source of mercury exposure in preterm infants.
J Pediatr
; 166(6): 1533-5, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25812777
14.
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial.
Eur J Heart Fail
; 26(1): 130-139, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37933184
15.
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trial.
Eur J Heart Fail
; 25(1): 87-94, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36181769
16.
Trajectory and correlates of pulmonary congestion by lung ultrasound in patients with acute myocardial infarction: insights from PARADISE-MI.
Eur Heart J Acute Cardiovasc Care
; 12(3): 155-164, 2023 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36649251
17.
Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MI.
J Am Heart Assoc
; 12(17): e028942, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37609931
18.
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial.
Circ Heart Fail
; 16(5): e010259, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37125529
19.
Knowledge about self-efficacy and outcomes in patients with heart failure and reduced ejection fraction.
Eur J Heart Fail
; 25(10): 1831-1839, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369637
20.
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
Eur J Heart Fail
; 25(9): 1606-1618, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37401511